| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vanda Pharmaceuticals Inc. (VNDA) has 1 insider with recent SEC Form 4 filings, including 0 buys and 14 sells. VNDA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.34M | $14.01M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2019 | Kelly James Patrick | EVP &Chief Financial Officer | Sell | 6,061 | $26.37 | $159,810.78 | -1.0% | |
| Jan 2, 2019 | Reverberi Gian Piero | SVP &Chief Commercial Officer | Sell | 1,130 | $26.59 | $30,042.35 | -0.4% | |
| Mar 1, 2018 | Polymeropoulos Mihael Hristos77 | President And CEO | Sell | 60,966 | $18.72 | $1,141,003.08 | -4.9% | |
| Mar 1, 2018 | Kelly James Patrick | EVP &Chief Financial Officer | Sell | 8,532 | $18.72 | $159,712.21 | -4.1% | |
| Mar 1, 2018 | Gulino Richard L. | SVP, General Counsel &Sec. | Sell | 3,660 | $18.71 | $68,473.11 | -3.1% | |
| Mar 1, 2018 | Birznieks Gunther61 | SVP, Business Development | Sell | 8,525 | $18.72 | $159,605.05 | -5.7% | |
| Jan 2, 2018 | Polymeropoulos Mihael Hristos77 | President And CEO | Sale+OE | 191,760 | $15.30 | $2,933,126.92 | -7.7% | |
| Jan 2, 2018 | Kelly James Patrick | EVP &Chief Financial Officer | Sale+OE | 9,155 | $15.35 | $140,493.55 | -5.2% | |
| Jan 2, 2018 | Gulino Richard L. | SVP, General Counsel &Sec. | Sale+OE | 10,367 | $15.20 | $157,564.92 | -10.5% | |
| Jan 2, 2018 | Birznieks Gunther61 | SVP, Business Development | Sell | 8,568 | $15.26 | $130,776.81 | -6.7% |